Biography and Research Information
OverviewAI-generated summary
Ali S. Taha's research interests span multiple disciplines, as evidenced by his diverse publications. His work includes systematic reviews on health-related topics, such as patient navigators for chronic kidney disease and kidney failure. He has also investigated the resurgence of synthetic cannabinoid receptor agonists and their clinical implications, as well as the role of the microbiome in gastric mucosal protection for aspirin users.
Taha's research also extends into materials science and engineering, with publications on electrochemical sensors modified with nanodisks for cardiovascular drug detection. His work has also touched upon decentralized finance, exploring maximal extractable value, and multi-robot fleet management, focusing on resilient autonomy. Further research areas include risk factors and biomarkers in Iraqi COVID-19 patients and the impact of hotel green marketing on consumer purchasing behavior.
Taha holds a high-impact researcher designation, indicated by an h-index of 26 and over 3,100 citations across 134 publications. He has collaborated with Grover P. Miller at the University of Arkansas for Medical Sciences on shared publications.
Metrics
- h-index: 26
- Publications: 134
- Citations: 3,133
Selected Publications
-
Drug-Drug Interaction Dataset Derived from FDA 2026 DailyMed Drug Labels (2026)
-
Drug-Drug Interaction Dataset Derived from FDA 2026 DailyMed Drug Labels (2026)
-
Drug-Drug Interaction Dataset Derived from FDA 2026 DailyMed Drug Labels (2026)
-
The resurgence of synthetic cannabinoid receptor agonists as adulterants in the Era of Cannabis legalization: Lessons from prior epidemics and clinical implications (2025)
Collaboration Network
Top Collaborators
- The resurgence of synthetic cannabinoid receptor agonists as adulterants in the Era of Cannabis legalization: Lessons from prior epidemics and clinical implications
- The resurgence of synthetic cannabinoid receptor agonists as adulterants in the Era of Cannabis legalization: Lessons from prior epidemics and clinical implications
Similar Researchers
Based on overlapping research topics